U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Description

YTTRIUM Y-90 (YTRACIS®, YTTRIGA®) is a radioactive form of the chemical element yttrium. It is used for radiolabelling other medicines. An example of its use is the treatment of some type of tumors, where the radiolabelled medicine carries the radioactivity to the site of a tumor to destroy the tumor cells.

Approval Year

Unknown
139594
Name Type Language
YTTRIUM Y-90 IBRITUMOMAB TIUXETAN
Common Name English
90Y-IBRITUMOMAB
Common Name English
90Y IBRITUMOMAB TIUXETAN
Common Name English
YTTRIUM Y 90 IBRITUMOMAB TIUXETAN [USP IMPURITY]
Common Name English
YTTRIUM (90Y) IBRITUMOMAB TIUXETAN
Common Name English
IBRITUMOMAB TIUXETAN Y-90
Common Name English
IBRITUMOMAB TIUXETAN YTTRIUM Y-90
Common Name English
YTTRIUM Y 90 IBRITUMOMAB TIUXETAN
USP  
Common Name English
Yttrium (90Y) ibritumomab tiuxetan [WHO-DD]
Common Name English
(90)Y-IBRITUMOMAB TIUXETAN
Common Name English
Classification Tree Code System Code
WHO-ATC V10XX02
Created by admin on Fri Dec 15 16:44:46 GMT 2023 , Edited by admin on Fri Dec 15 16:44:46 GMT 2023
WHO-VATC QV10XX02
Created by admin on Fri Dec 15 16:44:46 GMT 2023 , Edited by admin on Fri Dec 15 16:44:46 GMT 2023
NCI_THESAURUS C1511
Created by admin on Fri Dec 15 16:44:46 GMT 2023 , Edited by admin on Fri Dec 15 16:44:46 GMT 2023
NCI_THESAURUS C129819
Created by admin on Fri Dec 15 16:44:46 GMT 2023 , Edited by admin on Fri Dec 15 16:44:46 GMT 2023
Code System Code Type Description
DRUG BANK
DBSALT001768
Created by admin on Fri Dec 15 16:44:46 GMT 2023 , Edited by admin on Fri Dec 15 16:44:46 GMT 2023
PRIMARY
NCI_THESAURUS
C1812
Created by admin on Fri Dec 15 16:44:46 GMT 2023 , Edited by admin on Fri Dec 15 16:44:46 GMT 2023
PRIMARY
EVMPD
SUB30555
Created by admin on Fri Dec 15 16:44:46 GMT 2023 , Edited by admin on Fri Dec 15 16:44:46 GMT 2023
PRIMARY
ChEMBL
CHEMBL2108667
Created by admin on Fri Dec 15 16:44:46 GMT 2023 , Edited by admin on Fri Dec 15 16:44:46 GMT 2023
PRIMARY
LACTMED
Yttrium 90 Ibritumomab Tiuxetan
Created by admin on Fri Dec 15 16:44:46 GMT 2023 , Edited by admin on Fri Dec 15 16:44:46 GMT 2023
PRIMARY
FDA UNII
QA846JAV5B
Created by admin on Fri Dec 15 16:44:46 GMT 2023 , Edited by admin on Fri Dec 15 16:44:46 GMT 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966